难治性突发性聋研究进展
谭鑫源;张宏征
1:南方医科大学珠江医院耳鼻咽喉头颈外科中心
摘要关键词基金项目(Foundation):作者参考文献1 Xie L,Hou J,Qi H,et al.Histone acetylation in refractory sudden sensorineural hearing loss patients after intratympanic methylprednisolone perfusion[J].J Laryngol Otol,2019,133(10):895-902.
2 于春刚，李健东.鼓室内注射激素联合高压氧治疗难治性突聋的近期疗效观察[J].听力学及言语疾病杂志，2019,27(1):88-90.
3 Nakagawa T,Kumakawa K,Usami S,et al.A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment[J].BMC Med,2014,12:219.DOI:10.1186/s12916-014-0219-x.
4 Marx M,Younes E,Chandrasekhar SS,et al.International consensus (ICON) on treatment of sudden sensorineural hearing loss[J].Eur Ann Otorhinolaryngol Head Neck Dis,2018,135(1S):S23-S28.
5 Zhou QQ,Dai YH,Du XP,et al.Aminophylline restores glucocorticoid sensitivity in a guinea pig model of sudden sensorineural hearing loss induced by lipopolysaccharide[J].Sci Rep,2017,7(1):2736.DOI:10.1038/s41598-017-02956-x.
6 Hou J,She W,Du X,et al.Histone deacetylase 2 in sudden sensorineural hearing loss patients in response to intratympanic methylprednisolone perfusion[J].Otolaryngol Head Neck Surg,2016,154(1):164-170.
7 Xie L,Zhou Q,Chen X,et al.Elucidation of the HDAC2/Sp1/miR-204-5p/Bcl-2 axis as a modulator of cochlear apoptosis via in vivo/in vitro models of acute hearing loss[J].Mol Ther Nucleic Acids,2021,23:1093-1109.
8 Kumagami H,Terakado M,Takahashi H.Distribution of glucocorticoid receptors and 11β-hydroxysteroid dehydrogenase isoforms in the human inner ear[J].Otol Neurotol,2013,34(1):151-157.
9 Vandevyver S,Dejager L,Tuckermann J,et al.New insights into the anti-inflammatory mechanisms of glucocorticoids:an emerging role for glucocorticoid-receptor-mediated transactivation[J].Endocrinology,2013,154(3):993-1007.
10 Quatrini L,Ugolini S.New insights into the cell- and tissue-specificity of glucocorticoid actions[J].Cell Mol Immunol,2021,18(2):269-278.
11 Dendoncker K,Timmermans S,Vandewalle J,et al.TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile[J].Proc Natl Acad Sci USA,2019,116(26):12942-12951.
12 刘谦虚，赵晓明，汪志伟，等.糖皮质激素受体与突发性聋疗效关系的研究[J].中华耳科学杂志，2015,13(2):340-343.
13 陈郑礼，孙瑜，王俊杰，等.MIF抵抗糖皮质激素的抗炎效应及其机制[J].中国免疫学杂志，2013,29(11):1146-1150.
14 Calandra T,Bucala R.Macrophage migration inhibitory factor (MIF):a glucocorticoid counter-regulator within the immune system[J].Crit Rev Immunol,2017,37(2-6):359-370.
15 Kang I,Bucala R.The immunobiology of MIF:function,genetics and prospects for precision medicine[J].Nat Rev Rheumatol,2019,15(7):427-437.
16 Tong B,Wang Q,Dai Q,et al.Efficacy of various corticosteroid treatment modalities for the initial treatment of idiopathic sudden hearing loss:a prospective randomized controlled trial[J].Audiol Neurootol,2021,26(1):45-52.
17 Mirian C,Ovesen T.Intratympanic vs systemic corticosteroids in first-line treatment of Idiopathic sudden sensorineural hearing loss:a systematic review and meta-analysis[J].JAMA Otolaryngol Head Neck Surg,2020,146(5):421-428.
18 Salvador P,Moreira da Silva F,Fonseca R.Idiopathic sudden sensorineural hearing loss:effectiveness of salvage treatment with low-dose intratympanic dexamethasone[J].J Otol,2021,16(1):6-11.
19 孙海丽，于湛，魏永祥.局部给药途径对内耳耳蜗作用机制的研究[J].中华耳科学杂志，2020,18(5):927-931.
20 魏浩，陆玲，王茂华，等.鼓室内应用地塞米松补救性治疗难治性突发性聋相关文献的Meta分析[J].听力学及言语疾病杂志，2019,27(6):641-645.
21 程雨芳，刘爱国，刘磊.鼓室应用地塞米松或甲泼尼龙治疗突发性聋疗效比较的Meta分析[J].听力学及言语疾病杂志，2020,28(6):692-696.
22 Berjis N,Soheilipour S,Musavi A,et al.Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss[J].Adv Biomed Res,2016,5:111.DOI:10.4103/2277-9175.184277.
23 Liebau A,Pogorzelski O,Salt AN,et al.Hearing changes after intratympanically applied steroids for primary therapy of sudden hearing loss:a meta-analysis using mathematical simulations of drug delivery protocols[J].Otol Neurotol,2017,38(1):19-30.
24 Kordi? ?,Battelino S.The role of high dose intratympanic dexamethasone as salvage therapy for idiopathic sudden sensorineural hearing loss[J].J Int Adv Otol,2017,13(3):318-321.
25 Olex-Zarychta D.Hyperbaric oxygenation as adjunctive therapy in the treatment of sudden sensorineural hearing loss[J].Int J Mol Sci,2020,21(22).DOI:10.3390/ijms21228588.
26 Hayashi Y,Yamamoto N,Nakagawa T,et al.Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice[J].Mol Cell Neurosci,2013,56:29-38.DOI:10.1016/j.mcn.2013.03.003.
27 Xia L,Liu J,Sun Y,et al.Rosiglitazone improves glucocorticoid resistance in a sudden sensorineural hearing loss by promoting MAP kinase phosphatase-1 expression[J].Mediators Inflamm,2019,2019:7915730.DOI:10.1155/2019/7915730.
28 Reddy AT,Lakshmi SP,Banno A,et al.Glucocorticoid receptor α mediates roflumilast’s ability to restore dexamethasone sensitivity in COPD[J].Int J Chron Obstruct Pulmon Dis,2020,15:125-134.DOI:10.2147/COPD.S230188.